Sisram Medical Ltd (1696)

Currency in HKD
1.95
-0.10(-4.88%)
Closed·
High dividend Yield
1696 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.932.02
52 wk Range
1.885.78
Key Statistics
Bid/Ask
1.95 / 2.00
Prev. Close
1.95
Open
1.93
Day's Range
1.93-2.02
52 wk Range
1.88-5.78
Volume
95.6K
Average Volume (3m)
275.96K
1-Year Change
-65.8172%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1696 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.41
Upside
+126.06%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Sisram Medical Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.41
(+126.06% Upside)

Sisram Medical Ltd Earnings Call Summary for H1/2026

  • H1 2026 revenue rose 3.6% to $171.4M, but adjusted net profit fell to $5.04M from $12M as Sisram invested heavily in China injectables.
  • Asia-Pacific became largest region at 45% of revenue, up 19.1% YoY; injectable revenue surged 54.2% while North America remained weak.
  • Gross margin compressed to 56.7% from 60% due to strategic spending on first pharmaceutical product launch and China market expansion.
  • Management expects H2 revenue improvement, targeting DAXXIFY expansion and Profhilo China approval by H2 2027; shares fell 1.62% to $2.13.
  • Beijing Miyun facility began local production in June to reduce costs and delivery times; DAXXIFY reached 30,000+ vials across 500 premium clinics.
Last Updated: 2026-08-20, 04:46 a/m
Read Full Transcript

Earnings

Latest Release
Aug 19, 2026
EPS / Forecast
-- / --
Revenue / Forecast
171.42M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.02%
Dividend Yield
4.63%
Industry Median 2.63%
Annualized payout
0.10
Paid annually
5-Years Growth
+6.22%
Growth Streak

1696 Income Statement

Compare 1696 to Peers and Sector

Metrics to compare
1696
Peers
Sector
Relationship
P/E Ratio
10.1x−0.9x−0.4x
PEG Ratio
−0.23−0.050.00
Price/Book
0.2x2.7x2.6x
Price / LTM Sales
0.3x2.2x3.0x
Upside (Analyst Target)
126.1%69.8%58.0%
Fair Value Upside
Unlock19.4%8.0%Unlock

Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers a portfolio of products and treatments for clinical aesthetic indications, including hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. It also engages in pharmaceutical research and development activities. The company offers its products under the Alma, LMNT, Copulla, Profhilo, and Aliaxin brands. Sisram Medical Ltd was founded in 1999 and is headquartered in Caesarea, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.20M0.47%4.27M
Other Institutional Investors
334.50M71.42%648.94M
Public Companies & Retail Investors
131.64M28.11%255.38M
Total
468.34M100.00%908.59M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fosun Pharma Industrial Pte Ltd.71.42%334,504,800648,939
China Asset Management Co. Ltd.0.17%796,8001,546

FAQ

What Is the Sisram Medical (1696) Stock Price Today?

The Sisram Medical stock price today is 1.95 HKD.

What Stock Exchange Does Sisram Medical Trade On?

Sisram Medical is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Sisram Medical?

The stock symbol for Sisram Medical is "1696."

Does Sisram Medical Pay Dividends? What’s The Current Dividend Yield?

The Sisram Medical dividend yield is 4.63%.

What Is the Sisram Medical Market Cap?

As of today, Sisram Medical market cap is 910.93M HKD.

What Is Sisram Medical's Earnings Per Share (TTM)?

The Sisram Medical EPS (TTM) is 0.02.

From a Technical Analysis Perspective, Is 1696 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sisram Medical Stock Split?

Sisram Medical has split 0 times.

How Many Employees Does Sisram Medical Have?

Sisram Medical has 1043 employees.

What is the current trading status of Sisram Medical (1696)?

As of Sep 26, 2026, Sisram Medical (1696) is trading at a price of 1.95 HKD, with a previous close of 1.95 HKD. The stock has fluctuated within a day range of 1.93 HKD to 2.02 HKD, while its 52-week range spans from 1.88 HKD to 5.78 HKD.

What Is Sisram Medical (1696) Price Target According to Analysts?

The average 12-month price target for Sisram Medical is 4.41 HKD, with a high estimate of 4.5101849 HKD and a low estimate of 4.3062461 HKD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.